Arogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...

Diabetes extends far beyond blood sugar management, affecting vital organs throughout the body. This chronic condition, ...

Regillo discussed treatment with panretinal photocoagulation ... When to initiate therapy for proliferative diabetic retinopathy. Presented at: OSN New York and OSN New York Retina; Nov.

Experiencing fatigue, blurred vision, and unexplained weight loss, a young man sought medical consultation and was informed ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

This condition is called diabetic retinopathy. In its early stages, diabetic retinopathy may not cause noticeable ... making ...

Diabetic retinopathy is the leading cause of blindness in the working population in the U.S., but it does not need to be. We have a proven target, VEGF, and proven treatments for decades, the ...

The start-up – founded by investment group Flagship Pioneering – said that OPL-0401 did not meet either the primary or ...

Striking a balance between innovation and responsibility is imperative. By prioritizing transparency, adhering to robust ...